Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0P1YH
|
||||
| Former ID |
DIB000922
|
||||
| Drug Name |
S-1746
|
||||
| Indication | Cerebrovascular ischaemia [ICD9: 434.91; ICD10:I61-I63] | Discontinued in Phase 1 | [1] | ||
| Company |
Shionogi & Co Ltd
|
||||
| Target and Pathway | |||||
| Target(s) | NMDA receptor | Target Info | Antagonist | [2] | |
| Glutamate receptor AMPA subtype | Target Info | Antagonist | [2] | ||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016496) | ||||
| REF 2 | 1,026 experimental treatments in acute stroke. Ann Neurol. 2006 Mar;59(3):467-77. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.